Works matching AU Kadowaki, Shigenori


Results: 84
    1
    2
    3
    4
    5

    A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09).

    Published in:
    Targeted Oncology, 2023, v. 18, n. 3, p. 359, doi. 10.1007/s11523-023-00961-x
    By:
    • Kawabata, Ryohei;
    • Izawa, Naoki;
    • Suzuki, Takahisa;
    • Nagahisa, Yoshio;
    • Nishikawa, Kazuhiro;
    • Takahashi, Masazumi;
    • Nakamura, Masato;
    • Ishiguro, Atsushi;
    • Katsuya, Hiroo;
    • Hihara, Jun;
    • Manaka, Dai;
    • Negoro, Yuji;
    • Tsuji, Akihito;
    • Takahashi, Takao;
    • Kochi, Mitsugu;
    • Azuma, Mizutomo;
    • Kadowaki, Shigenori;
    • Michimae, Hirofumi;
    • Sunakawa, Yu;
    • Ichikawa, Wataru
    Publication type:
    Article
    6
    7
    8
    9

    Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1123, doi. 10.1007/s00432-022-03979-2
    By:
    • Matsubara, Yuki;
    • Masuishi, Toshiki;
    • Ogata, Takatsugu;
    • Nakazawa, Taiko;
    • Kato, Kyoko;
    • Nozawa, Kazuki;
    • Narita, Yukiya;
    • Honda, Kazunori;
    • Bando, Hideaki;
    • Taniguchi, Hiroya;
    • Kadowaki, Shigenori;
    • Ando, Masashi;
    • Tajika, Masahiro;
    • Muro, Kei
    Publication type:
    Article
    10

    Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 6, p. 1238, doi. 10.1007/s10120-019-00973-5
    By:
    • Takahari, Daisuke;
    • Chin, Keisho;
    • Ishizuka, Naoki;
    • Takashima, Atsuo;
    • Minashi, Keiko;
    • Kadowaki, Shigenori;
    • Nishina, Tomohiro;
    • Nakajima, Takako Eguchi;
    • Amagai, Kenji;
    • Machida, Nozomu;
    • Goto, Masahiro;
    • Taku, Keisei;
    • Wakatsuki, Takeru;
    • Shoji, Hirokazu;
    • Hironaka, Shuichi;
    • Boku, Narikazu;
    • Yamaguchi, Kensei
    Publication type:
    Article
    11
    12
    13
    14

    Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis.

    Published in:
    Gastric Cancer, 2012, v. 15, n. 3, p. 245, doi. 10.1007/s10120-011-0101-x
    By:
    • Shitara, Kohei;
    • Morita, Satoshi;
    • Fujitani, Kazumasa;
    • Kadowaki, Shigenori;
    • Takiguchi, Nobuhiro;
    • Hirabayashi, Naoki;
    • Takahashi, Masazumi;
    • Takagi, Masakazu;
    • Tokunaga, Yukihiko;
    • Fukushima, Ryoji;
    • Munakata, Yasuhiro;
    • Nishikawa, Kazuhiro;
    • Takagane, Akinori;
    • Tanaka, Takaho;
    • Sekishita, Yoshiaki;
    • Sakamoto, Junichi;
    • Tsuburaya, Akira
    Publication type:
    Article
    15

    Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.

    Published in:
    Oncology, 2017, v. 93, n. 5, p. 329, doi. 10.1159/000479280
    By:
    • Komori, azusa;
    • Taniguchi, Hiroya;
    • Hamauchi, Satoshi;
    • Masuishi, Toshiki;
    • Kito, Yosuke;
    • Narita, Yukiya;
    • Tsushima, Takahiro;
    • Ishihara, Makoto;
    • Todaka, akiko;
    • Tanaka, Tsutomu;
    • Yokota, Tomoya;
    • Kadowaki, Shigenori;
    • Machida, Nozomu;
    • Ura, Takashi;
    • Fukutomi, akira;
    • ando, Masashi;
    • Onozawa, Yusuke;
    • Tajika, Masahiro;
    • Yasui, Hirofumi;
    • Muro, Kei
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 357, doi. 10.1007/s00280-015-2806-8
    By:
    • Nomura, Motoo;
    • Oze, Isao;
    • Abe, Tetsuya;
    • Komori, Azusa;
    • Narita, Yukiya;
    • Masuishi, Toshiki;
    • Taniguchi, Hiroya;
    • Kadowaki, Shigenori;
    • Ura, Takashi;
    • Andoh, Masashi;
    • Kawai, Ryosuke;
    • Uemura, Norihisa;
    • Ishihara, Makoto;
    • Tanaka, Tsutomu;
    • Tajika, Masahiro;
    • Niwa, Yasumasa;
    • Muro, Kei;
    • Muto, Manabu
    Publication type:
    Article
    23
    24
    25
    26

    Chronological improvement of survival in patients with advanced gastric cancer over 15 years.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241229428
    By:
    • Ogata, Takatsugu;
    • Narita, Yukiya;
    • Oze, Isao;
    • Kumanishi, Ryosuke;
    • Nakazawa, Taiko;
    • Matsubara, Yuki;
    • Kodama, Hiroyuki;
    • Nakata, Akinobu;
    • Honda, Kazunori;
    • Masuishi, Toshiki;
    • Bando, Hideaki;
    • Taniguchi, Hiroya;
    • Kadowaki, Shigenori;
    • Ando, Masashi;
    • Ito, Seiji;
    • Tajika, Masahiro;
    • Muro, Kei
    Publication type:
    Article
    27
    28

    Conversion from Radical Esophagectomy to Definitive Chemoradiotherapy After Neoadjuvant Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma: Treatment Options Based on Chemotherapy Response.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2025, v. 32, n. 5, p. 3157, doi. 10.1245/s10434-025-16955-0
    By:
    • Narita, Kiyoshi;
    • Higaki, Eiji;
    • Abe, Tetsuya;
    • Fujieda, Hironori;
    • Hashimoto, Shingo;
    • Kadowaki, Shigenori;
    • Tajika, Masahiro;
    • Kodaira, Takeshi;
    • Muro, Kei;
    • Shimizu, Yasuhiro
    Publication type:
    Article
    29

    Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-Fluorouracil.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 2, p. 712, doi. 10.1245/s10434-020-08865-0
    By:
    • Abe, Tetsuya;
    • Higaki, Eiji;
    • Hosoi, Takahiro;
    • Nagao, Takuya;
    • Bando, Hideaki;
    • Kadowaki, Shigenori;
    • Muro, Kei;
    • Tanaka, Tsutomu;
    • Tajika, Masahiro;
    • Niwa, Yasumasa;
    • Shimizu, Yasuhiro
    Publication type:
    Article
    30
    31

    An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7).

    Published in:
    Cancers, 2021, v. 13, n. 4, p. 805, doi. 10.3390/cancers13040805
    By:
    • Kawakami, Hisato;
    • Hironaka, Shuichi;
    • Esaki, Taito;
    • Chayama, Kazuaki;
    • Tsuda, Masahiro;
    • Sugimoto, Naotoshi;
    • Kadowaki, Shigenori;
    • Makiyama, Akitaka;
    • Machida, Nozomu;
    • Hirano, Hidekazu;
    • Hirata, Kenro;
    • Hara, Hiroki;
    • Yabusaki, Hiroshi;
    • Komatsu, Yoshito;
    • Muro, Kei;
    • Wijnhoven, Bas
    Publication type:
    Article
    32
    33

    Paclitaxel plus cetuximab versus nivolumab for patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 3, p. 480, doi. 10.1007/s10147-025-02698-1
    By:
    • Kodama, Hiroyuki;
    • Kadowaki, Shigenori;
    • Ishizuka, Yasunobu;
    • Wakabayashi, Munehiro;
    • Sakakida, Tomoki;
    • Honda, Kazunori;
    • Masuishi, Toshiki;
    • Narita, Yukiya;
    • Taniguchi, Hiroya;
    • Ando, Masashi;
    • Kishikawa, Toshihiro;
    • Terada, Hoshino;
    • Beppu, Shintaro;
    • Nishikawa, Daisuke;
    • Suzuki, Hidenori;
    • Hanai, Nobuhiro;
    • Muro, Kei
    Publication type:
    Article
    34
    35

    Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 764, doi. 10.1007/s10147-024-02508-0
    By:
    • Iwaki, Sho;
    • Kadowaki, Shigenori;
    • Honda, Kazunori;
    • Narita, Yukiya;
    • Masuishi, Toshiki;
    • Taniguchi, Hiroya;
    • Ando, Masashi;
    • Muro, Kei;
    • Sawabe, Michi;
    • Suzuki, Hidenori;
    • Nishikawa, Daisuke;
    • Beppu, Shintaro;
    • Terada, Hoshino;
    • Kishikawa, Toshihiro;
    • Kawakita, Daisuke;
    • Hanai, Nobuhiro
    Publication type:
    Article
    36

    Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 10, p. 1237, doi. 10.1007/s10147-023-02397-9
    By:
    • Mishima, Saori;
    • Naito, Yoichi;
    • Akagi, Kiwamu;
    • Hayashi, Naomi;
    • Hirasawa, Akira;
    • Hishiki, Tomoro;
    • Igarashi, Ataru;
    • Ikeda, Masafumi;
    • Kadowaki, Shigenori;
    • Kajiyama, Hiroaki;
    • Kato, Motohiro;
    • Kenmotsu, Hirotsugu;
    • Kodera, Yasuhiro;
    • Komine, Keigo;
    • Koyama, Takafumi;
    • Maeda, Osamu;
    • Miyachi, Mitsuru;
    • Nishihara, Hiroshi;
    • Nishiyama, Hiroyuki;
    • Ohga, Shouichi
    Publication type:
    Article
    37

    Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 7, p. 827, doi. 10.1007/s10147-023-02345-7
    By:
    • Naito, Yoichi;
    • Mishima, Saori;
    • Akagi, Kiwamu;
    • Hayashi, Naomi;
    • Hirasawa, Akira;
    • Hishiki, Tomoro;
    • Igarashi, Ataru;
    • Ikeda, Masafumi;
    • Kadowaki, Shigenori;
    • Kajiyama, Hiroaki;
    • Kato, Motohiro;
    • Kenmotsu, Hirotsugu;
    • Kodera, Yasuhiro;
    • Komine, Keigo;
    • Koyama, Takafumi;
    • Maeda, Osamu;
    • Miyachi, Mitsuru;
    • Nishihara, Hiroshi;
    • Nishiyama, Hiroyuki;
    • Ohga, Shouichi
    Publication type:
    Article
    38
    39

    Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 8, p. 941, doi. 10.1007/s10147-023-02360-8
    By:
    • Mishima, Saori;
    • Naito, Yoichi;
    • Akagi, Kiwamu;
    • Hayashi, Naomi;
    • Hirasawa, Akira;
    • Hishiki, Tomoro;
    • Igarashi, Ataru;
    • Ikeda, Masafumi;
    • Kadowaki, Shigenori;
    • Kajiyama, Hiroaki;
    • Kato, Motohiro;
    • Kenmotsu, Hirotsugu;
    • Kodera, Yasuhiro;
    • Komine, Keigo;
    • Koyama, Takafumi;
    • Maeda, Osamu;
    • Miyachi, Mitsuru;
    • Nishihara, Hiroshi;
    • Nishiyama, Hiroyuki;
    • Ohga, Shouichi
    Publication type:
    Article
    40

    Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 644, doi. 10.1007/s10147-023-02316-y
    By:
    • Ando, Masashi;
    • Honda, Kazunori;
    • Hosoda, Waki;
    • Matsubara, Yuki;
    • Kumanishi, Ryosuke;
    • Nakazawa, Taiko;
    • Ogata, Takatsugu;
    • Nakata, Akinobu;
    • Kodama, Hiroyuki;
    • Masuishi, Toshiki;
    • Narita, Yukiya;
    • Taniguchi, Hiroya;
    • Kadowaki, Shigenori;
    • Muro, Kei
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.

    Published in:
    International Journal of Clinical Oncology, 2016, v. 21, n. 5, p. 890, doi. 10.1007/s10147-016-0963-3
    By:
    • Nomura, Motoo;
    • Oze, Isao;
    • Kodaira, Takeshi;
    • Abe, Tetsuya;
    • Komori, Azusa;
    • Narita, Yukiya;
    • Masuishi, Toshiki;
    • Taniguchi, Hiroya;
    • Kadowaki, Shigenori;
    • Ura, Takashi;
    • Andoh, Masashi;
    • Tachibana, Hiroyuki;
    • Uemura, Norihisa;
    • Tajika, Masahiro;
    • Niwa, Yasumasa;
    • Muto, Manabu;
    • Muro, Kei
    Publication type:
    Article
    47
    48
    49

    Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective study.

    Published in:
    Oncologist, 2025, v. 30, n. 3, p. 1, doi. 10.1093/oncolo/oyaf018
    By:
    • Watanabe, Takane;
    • Oka, Hiroki;
    • Nagashima, Kengo;
    • Nishi, Hideaki;
    • Kumai, Yoshihiko;
    • Iijima, Hiroaki;
    • Okami, Kenji;
    • Shimizu, Yasushi;
    • Kano, Satoshi;
    • Ito, Kazue;
    • Yamazaki, Tomoko;
    • Takahashi, Hideaki;
    • Oridate, Nobuhiko;
    • Yokota, Tomoya;
    • Koyama, Taiji;
    • Kiyota, Naomi;
    • Sato, Yasuyoshi;
    • Takahashi, Shunji;
    • Kato, Kyoko;
    • Kadowaki, Shigenori
    Publication type:
    Article
    50

    Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study.

    Published in:
    Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae223
    By:
    • Nakata, Akinobu;
    • Hashimoto, Naoya;
    • Narita, Yukiya;
    • Wakabayashi, Munehiro;
    • Kodama, Hiroyuki;
    • Ogata, Takatsugu;
    • Honda, Kazunori;
    • Masuishi, Toshiki;
    • Taniguchi, Hiroya;
    • Kadowaki, Shigenori;
    • Ando, Masashi;
    • Endo, Yuka;
    • Kotani, Haruru;
    • Kataoka, Ayumi;
    • Hattori, Masaya;
    • Yoshimura, Akiyo;
    • Sawaki, Masataka;
    • Nozawa, Kazuki;
    • Oze, Isao;
    • Iwata, Hiroji
    Publication type:
    Article